VEGFA and viral infectious disease: TG-100801 is administered noninvasively as an eye drop and has been designed to suppress VEGF-mediated leakage and additional kinase targets associated with inflammation, edema, and angiogenesis in several pathological eye conditions, including viral infections [144,145].